S ome intravenous medication errors are associated with significant risks. In fact, many high-alert medications that are known to cause patient harm are administered by the IV route. An aspect that may be overlooked when discussing serious errors associated with IV medication is too-rapid administration.
As reported in the ISMP Medication Safety Alert!, the Institute for Safe Medication Practices (ISMP) has received several reports of errors associated with rapid administration. 1 Sometimes they are minor, as with the administration of IV ampicillin. In other cases, the results have been more serious, such with the rapid administration of IV vancomycin, which can lead to severe hypotension and flushing of the upper body (Red Neck Syndrome). Another example of a more serious nature includes the rapid administration of potassium chloride injection concentrate, especially when prescribers use the term "bolus." In addition, IV Versed (midazolam) should be administered slowly while carefully monitoring the patient.
ISMP also received a case report in which a patient's death was attributed to the administration rate of an IV agent. An emergency room physician prescribed labetalol 20 mg IV push for a patient experiencing a hypertensive crisis. Because the patient was in the process of being transported to radiology, the nurse retrieved the drug quickly and administered the medication in a matter of seconds. The patient immediately went into cardiac arrest and could not be resuscitated. Later, after a retrospective review, the staff discovered several other cases in which rapid IV push labetalol may have contributed to patient harm.
According to a study from the United Kingdom, too rapid administration of IV medications occurs frequently. 2 The authors uncovered errors in 49% of all IV medications administered, 73% of these occurred with IV push doses. In 95% of the IV push errors, the dose was given faster than recommended. More than half of these errors were of potentially moderate severity.
To reduce patient harm from rapid injection of IV medications, practitioners need ready access to information about the maximum rate of administration for medications that have a high risk of adverse effects when given too rapidly. This information should be provided as an alert on pharmacy-applied product labels and as a special notation on computer-generated medication administration records.
The drug information pharma-cists at Facts and Comparisons have developed IV Push Medication Guidelines (Drugs Given by IV Push or Rapid Administration in Adults). It is available in wall chart format with this issue of Hospital Pharmacy and will be available as a PDA application this summer to serve as a helpful aid in developing or updating the IV push guidelines in your facility. The Guidelines include the drug name and indication, adult dose, infusion rate, dilution and final concentrations, and the adverse effects from too-rapid administration. The definitions of "IV push," "IV bolus" and "rapid administration" used in the chart refer to the direct injection of a medication over a period of 5 minutes or less. The chart does not include antineoplastics, most general anesthetics, or diagnostic agents. It is important that your IV push guidelines be reviewed frequently by all disciplines and be unit-or medical-service specific. A list of guidelines should be posted in all medication-use areas, or, as some hospitals have done, provided on a hospital intranet, PDA devices, or in a small pocket guide.
